For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $9.78 in the last session, up 15.06% from day before closing price of $8.50. In other words, the price has increased by $15.06 from its previous closing price. On the day, 2.64 million shares were traded.
Ratios:
We take a closer look at DNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 11 ’25 when Che Austin bought 99 shares for $8.93 per share.
Che Austin bought 99 shares of DNA for $791 on Jun 10 ’25. On Jun 09 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $7.75 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.41 while its Price-to-Book (P/B) ratio in mrq is 0.78.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $22.60, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is 32.21%, while the 200-Day Moving Average is calculated to be 14.21%.
Shares Statistics:
A total of 43.08M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 32.63% of the company’s shares, while institutions hold 57.97% stake in the company.
